Cellectar Biosciences Inc (CLRB)

3.03 -0.01 (-0.33%) USD  |  NASDAQ  |  Apr 19, 16:00
3.09 +0.06 (+1.98%) After-Hours: 19:16
More

Cellectar Biosciences Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2006. Upgrade now.
Date Value
June 29, 2023 3.027
June 28, 2023 3.027
June 27, 2023 3.011
June 26, 2023 3.109
June 23, 2023 3.044
June 22, 2023 3.175
June 21, 2023 3.256
June 20, 2023 3.338
June 16, 2023 3.371
June 15, 2023 3.355
June 14, 2023 3.420
June 13, 2023 2.929
June 12, 2023 2.913
June 09, 2023 3.003
June 08, 2023 2.88
June 07, 2023 2.949
June 06, 2023 2.805
June 05, 2023 2.913
June 02, 2023 2.749
June 01, 2023 2.667
May 31, 2023 2.553
May 30, 2023 2.464
May 26, 2023 2.504
May 25, 2023 2.455
May 24, 2023 2.504
Date Value
May 23, 2023 2.504
May 22, 2023 2.373
May 19, 2023 2.618
May 18, 2023 2.438
May 17, 2023 2.373
May 16, 2023 2.271
May 15, 2023 2.258
May 12, 2023 2.291
May 11, 2023 2.307
May 10, 2023 2.291
May 09, 2023 2.324
May 08, 2023 2.373
May 05, 2023 2.389
May 04, 2023 2.422
May 03, 2023 2.471
May 02, 2023 2.536
May 01, 2023 2.586
April 28, 2023 2.52
April 27, 2023 2.496
April 26, 2023 2.391
April 25, 2023 2.422
April 24, 2023 2.356
April 21, 2023 2.422
April 20, 2023 2.450
April 19, 2023 2.528

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

0.828
Minimum
May 12 2022
7.672
Maximum
Jun 25 2020
1.961
Average
1.690
Median

Price to Book Value Benchmarks

Perspective Therapeutics Inc 11.67
Eli Lilly and Co 64.11
Actinium Pharmaceuticals Inc 5.519
Bristol-Myers Squibb Co 3.361
Altimmune Inc 2.524

Price to Book Value Related Metrics

Price 3.03
Earnings Yield -102.3%
Market Cap 97.75M